Skip to content

Clinical trials

Phase 3 Lennox Gastaut Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lennox Gastaut Syndrome Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20102
20111
20121
20153
20162
20172
20191
20201
20212
20222
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Recruiting2
Active, not recruiting1
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals3
Takeda3
Eisai Inc.2
INSYS Therapeutics Inc2
Longboard Pharmaceuticals2
Lundbeck LLC2
Eisai Co., Ltd.1
Eisai Limited1
Epygenix1
GW Research Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lennox Gastaut Syndrome25
Epilepsy13
Seizures11
Epilepsies, Myoclonic8
Neurodevelopmental Disorders2
Syncope2
Epilepsy, Generalized1
Mental Disorders1
Neurologic Manifestations1
Rare Diseases1

Trials

Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.